HRS-8427

N/A

Report date: 2024/09/06 20:00:43
NME

Base Information

Drug NameHRS-8427
Drug Alias NameHRS-8427
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsHospital-acquired pneumoniaCommunity-acquired bacterial pneumoniaPyelonephritis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaCommunity-acquired bacterial pneumoniaPyelonephritis +[6] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A